End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 TWD | +6.07% | +4.38% | -11.49% |
Apr. 24 | UniPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | UniPharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 128M 3.93M | Sales 2023 | 103M 3.17M | Capitalization | 525M 16.13M |
---|---|---|---|---|---|
Net income 2022 | -6M -184K | Net income 2023 | -21M -645K | EV / Sales 2022 | 3.06 x |
Net cash position 2022 | 159M 4.87M | Net cash position 2023 | 174M 5.34M | EV / Sales 2023 | 3.41 x |
P/E ratio 2022 |
-85.3
x | P/E ratio 2023 |
-24.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.78% |
1 day | +6.07% | ||
1 week | +4.38% | ||
Current month | -4.03% | ||
1 month | -1.50% | ||
3 months | -6.09% | ||
6 months | -18.12% | ||
Current year | -11.49% |
Managers | Title | Age | Since |
---|---|---|---|
Liang Kuang Lin
CEO | Chief Executive Officer | - | 05-07-24 |
Hui Ling Chen
DFI | Director of Finance/CFO | - | 14-10-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Chen
CHM | Chairman | 69 | 15-06-04 |
Liang Kuang Lin
CEO | Chief Executive Officer | - | 05-07-24 |
Chia Lin Wang
BRD | Director/Board Member | - | 17-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 13.1 | +6.07% | 104,449 |
24-04-25 | 12.35 | -1.98% | 43,070 |
24-04-24 | 12.6 | -0.40% | 83,237 |
24-04-23 | 12.65 | +1.61% | 21,901 |
24-04-22 | 12.45 | -0.80% | 50,853 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-11.49% | 14.26M | |
-8.67% | 287M | |
+13.93% | 198M | |
+26.13% | 77.74M | |
+20.48% | 65.76M |
- Stock Market
- Equities
- 6621 Stock